Author:
Frye Björn C.,Schupp Jonas,Müller-Quernheim Joachim
Reference24 articles.
1. Bandyopadhyay D, Humbert M: An update on sarcoidosis-associated pulmonary hypertension. Current opinion in pulmonary medicine 26 (2020) 582–590
2. Baughman RP, Drent M, Kavuru M et al.: Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174 (2006) 795–802
3. Behr J, Prasse A, Kreuter M et al.: Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. The Lancet Respiratory medicine (2021)
4. Crommelin HA, van der Burg LM, Vorselaars AD et al.: Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab. Respir Med 115 (2016) 72–77
5. Drent M, Lower EE, De Vries J: Sarcoidosis-associated fatigue. Eur Respir J 40 (2012) 255–263